581
Views
2
CrossRef citations to date
0
Altmetric
Review

Rational combination strategies to enhance venetoclax activity and overcome resistance in hematologic malignancies

Pages 1292-1299 | Received 19 Jun 2017, Accepted 08 Aug 2017, Published online: 24 Aug 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Sumeet Mirgh, Archana Sharma, Bhaarat Folbs, Vishvdeep Khushoo, Jyotsna Kapoor, Narender Tejwani, Rayaz Ahmed, Narendra Agrawal, Partha S. Choudhary, Pallavi Mehta & Dinesh Bhurani. (2021) Daratumumab-based therapy after prior Azacytidine-Venetoclax in an octagenerian female with BPDCN (blastic plasmacytoid dendritic cell neoplasm) – a new perspective. Leukemia & Lymphoma 62:12, pages 3039-3042.
Read now

Articles from other publishers (1)

Christian Flotho, Sebastian Sommer & Michael Lübbert. (2018) DNA-hypomethylating agents as epigenetic therapy before and after allogeneic hematopoietic stem cell transplantation in myelodysplastic syndromes and juvenile myelomonocytic leukemia. Seminars in Cancer Biology 51, pages 68-79.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.